Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Gogo Extends $544.4M Term Loans to October 2030

Gogo Inc. filed a current report on November 6, 2026, disclosing that it and its wholly owned subsidiary Gogo Intermediate Holdings LLC entered into a third amendment to their 2021 credit agreement, converting a portion of existing term loans into new 2026 Extended Term …

Shwetambri Chauhan | 06 November 2026

Medicus Pharma Q3 2026: CD228V Named Lead Program

Medicus Pharma Ltd. filed a Form 425 on November 6, 2026, disclosing third-quarter 2026 financial results, a co-development and license agreement with Pfizer for CD228V, a non-binding letter of intent for a proposed SkinJect SPAC business combination at approximately $135 million pre-money enterprise valuation, …

Manish Choudhary | 06 November 2026

GPGI Inc. Q3 2026 10-Q: 289.9M Shares Outstanding

GPGI, Inc. (NYSE:GPGI) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing 289,901,892 shares of Class A common stock outstanding as of November 5, 2026.

Aakashdeep | 06 November 2026

BancFirst Posts $196.9M Net Income for Nine Months Ended Sept. 30, 2026

BancFirst Corporation filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the period ended September 30, 2026, and reporting results for both the third quarter and the first nine months of the fiscal year.

Anjali Anand | 06 November 2026

abrdn Gold ETF Trust NAV Falls to $39.75 in Q3 2026

abrdn Gold ETF Trust filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 6, 2026, reporting financial results and portfolio data for the three and nine months ended September 30, 2026.

Shwetambri Chauhan | 06 November 2026

Essent Group Q3 2026 10-Q: Balance Sheet and Key Figures

Essent Group Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the Securities and Exchange Commission, disclosing financial statements and related information for the third quarter of fiscal year 2026.

Anjali Anand | 06 November 2026

Telomir Pharmaceuticals Files Q3 2026 10-Q on Nasdaq

Telomir Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 6, 2026, covering the fiscal quarter ended September 30, 2026.

Aditi Sarkar | 06 November 2026

Blackstone REIT Posts $1.15B Net Loss for Nine Months Ended Sept. 30, 2026

Blackstone Real Estate Income Trust, Inc. filed its Form 10-Q with the SEC on November 6, 2026, covering the quarterly period ended September 30, 2026, disclosing a net loss of $296.1 million for the third quarter and $1.147 billion for the nine months ended …

Nitish Kishor | 06 November 2026

Chiron Real Estate Reports Q3 2026 Results

Chiron Real Estate Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 6, 2026, reporting a net loss of $5.7 million for the third quarter and net income of $68.2 million for the nine months …

Manish Choudhary | 06 November 2026

Creative Medical Posts $5.58M Nine-Month Net Loss Through Sept 2026

Creative Medical Technology Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting a net loss attributable to the company of $5,587,129 for the nine months ended September 30, 2026.

Aditi Sarkar | 06 November 2026
Support

Hi! How can we help you today?

Loading…